Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis workshop summary

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resist...

Full description

Bibliographic Details
Main Author:	Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB (corporate author, -)
Corporate Authors:	Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Corporate Author (corporate author), Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body (issuing body), Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body
Other Authors:	Nicholson, Anna, contributor (contributor)
Format:	eBook
Language:	Inglés
Published:	Washington, District of Columbia : National Academies Press [2013]
Edition:	1st ed
Subjects:	Multidrug-resistant tuberculosis > Prevention > Congresses. Business logistics > Congresses. International cooperation > Congresses.
See on Biblioteca Universitat Ramon Llull:	https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009621947206719